Drugs / Sputnik Light
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT04713488 | Jan → Jul 2021 | — | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04741061 Comparator | Feb → Dec 2021 | — | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sputnik-Light | “Sputnik-Light vector vaccine” NCT04741061 ↗ |
| Modality | Vaccine | “vector vaccine to help prevent the SARS-CoV-2-induced coronavirus infection” NCT04713488 ↗ |
| Route | Intramuscular | “solution for intramuscular injection” NCT04713488 ↗ |